PathAI, a provider of artificial intelligence-powered technology for pathology, has secured $165 million in Series C financing. D1 Capital Partners and Kaiser Permanente led the round.
Source: Press Release
PathAI locks in $165m Series C
PathAI, a provider of artificial intelligence-powered technology for pathology, has secured $165 million in Series C financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: